Skip to content
healthcare.dev

INVEGA TRINZA

NDC 50458-609, paliperidone palmitate, injection, suspension, extended release, from Janssen Pharmaceuticals, Inc.

Product NDC
50458-609
Status
Listed
Labeler
Janssen Pharmaceuticals, Inc
Dosage form
INJECTION, SUSPENSION, EXTENDED RELEASE
Route
INTRAMUSCULAR
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA207946
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/50458-609 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • PALIPERIDONE PALMITATE819 mg/2.63mL

Pharmacologic classes

Atypical Antipsychotic [EPC]

Package NDCNDC-11Package
50458-609-01504580609011 SYRINGE in 1 KIT (50458-609-01) / 1 mL in 1 SYRINGE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/c39e65d7-fa44-4e4c-8b12-a654d3ed0eae
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=50458-609
  • NADAC price for package 50458060901

    GET /v1/drugs/nadac/50458060901

Use it

Look up 50458-609 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/50458-609 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 50458-609. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.